Sai Parenteral's Limited
Promoter holding in Sai Parenteral's Limited has stayed unchanged at 51.16% for the last 2 quarters on record (since Mar 2026).
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Jun '26 | 51.16%=0.00 | 48.84%=0.00 |
| Mar '26 | 51.16% | 48.84% |
Compared with similar companies
Promoter holding in Sai Parenteral's Limited is lower than 57% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Sai Parenteral's Limited | 51.16% |
| Beta Drugs Limited | 58.91% |
| Panacea Biotec Limited | 72.48% |
| Venus Remedies Limited | 41.76% |
| Syncom Formulations (India) Limited | 50.57% |
| Indoco Remedies Limited | 58.86% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Sai Parenteral's Limited's promoter holding?
Promoters held 51.16% of Sai Parenteral's Limited as of 30 Jun 2026, and the public held 48.84%.
Has Sai Parenteral's Limited's promoter holding increased?
No, it was unchanged in the quarter to Jun 2026.
Are any promoter shares of Sai Parenteral's Limited pledged?
No promoter shares are recorded as pledged.
How does Sai Parenteral's Limited's promoter holding compare with similar companies?
Promoter holding in Sai Parenteral's Limited is lower than 57% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.